Grant C. Bogle - 18 Jun 2025 Form 4 Insider Report for Nuvalent, Inc. (NUVL)

Role
Director
Signature
/s/ Nathan McConarty, attorney-in-fact
Issuer symbol
NUVL
Transactions as of
18 Jun 2025
Net transactions value
$0
Form type
4
Filing time
20 Jun 2025, 16:33:47 UTC
Previous filing
09 Dec 2024

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Bogle Grant C. Director C/O NUVALENT, INC., ONE BROADWAY, 14TH FLOOR, CAMBRIDGE /s/ Nathan McConarty, attorney-in-fact 20 Jun 2025 0001646675

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NUVL Class A Common Stock Award $0 +2,647 +83% $0.000000 5,847 18 Jun 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUVL Stock Option (Right to Buy) Award $0 +4,147 $0.000000 4,147 18 Jun 2025 Class A Common Stock 4,147 $75.53 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of shares of Nuvalent, Inc. Class A Common Stock issuable under restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Nuvalent, Inc. Class A Common Stock. The RSUs vest in full on the earlier of June 18, 2026 or the date of Nuvalent, Inc.'s next annual meeting of stockholders, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
F2 The shares underlying this option vest in full on the earlier of June 18, 2026 or the date of Nuvalent, Inc.'s next annual meeting of stockholders, subject to continued service to Nuvalent, Inc. through the applicable vesting date.